Outcomes in the Era of Interferon-Free Direct-Acting Antiviral Therapy After Liver Transplantation in Patients with Hepatitis C Virus and Hepatocellular Carcinoma

BACKGROUND/AIMS: Several studies have shown improved outcome of liver transplant (LT) recipients with hepatitis C virus (HCV) since the widespread clinical use of interferon-free direct-acting antivirals (IFN-free DAAs). However, the association of IFN-free DAA therapy on tumor characteristics and o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismail, Mohamed Saleh, Mohamed, Islam, Polychronopoulou, Efstathia, Goss, John A, Kuo, Yong-Fang, Kanwal, Fasiha, Jalal, Prasun K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254565/
https://www.ncbi.nlm.nih.gov/pubmed/34235107
http://dx.doi.org/10.2147/JHC.S309354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254565/
https://www.ncbi.nlm.nih.gov/pubmed/34235107
http://dx.doi.org/10.2147/JHC.S309354

Ejemplares similares